Technology | Enterprise Imaging
February 13, 2017 — Vital Images Inc. announced that it will be demonstrating new image sharing capabilities for current ...
February 13, 2017
News | Cybersecurity
February 10, 2017 — With the Healthcare Information and Management Systems Society’s annual meeting (HIMSS17) scheduled ...
February 10, 2017
Feature | Heart Failure | Dave Fornell
In the past few years there have been a number of device therapies developed to treat heart failure (HF). This is partly ...
February 10, 2017Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
News | Cardiovascular Business | Jeff Zagoudis
Rep. Tom Price was confirmed by the U.S. Senate as the new secretary of the Department of Health and Human Services (HHS) by a 52-47 vote early Friday morning.
February 10, 2017
Technology | Enterprise Imaging
Vital Images Inc. will feature its Vitrea Modular Enterprise Imaging interoperability solutions at the 2017 Healthcare Information and Management Systems Society annual meeting (HIMSS 2017), Feb. 20–23 in Orlando, Fla.
February 09, 2017
Feature | Magnetic Resonance Imaging (MRI) | Jeff Zagoudis
February 9, 2017 — Sir Peter Mansfield, FRS, whose research aided the development of magnetic resonance imaging (MRI) in ...
February 09, 2017Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Videos | Medical 3-D Printing
When a pediatric patient at Children’s Hospital Los Angeles needed a custom-build stent to repair his pulmonary artery ...
February 09, 2017Technology
eHealth Technologies and HealtheConnections, a Syracuse-based regional health information organization (RHIO) supporting health information exchange (HIE) for the 11 counties of central and northern New York, have teamed up to share medical images across the care provider community.
February 09, 2017
February 9, 2017 — Janssen Research & Development LLC (Janssen) announced that the Phase 3 COMPASS trial is stopping ...
February 09, 2017Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Patient Engagement
Charleston Area Medical Center (CAMC) has documented reduced readmissions for congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD) and other chronic conditions. Driving this success is a comprehensive strategy supported by the SmarTigr interactive patient engagement and education system from TeleHealth Services.
February 09, 2017
News | Drug-Eluting Balloons
Medtronic plc announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a study of the IN.PACT Admiral drug-coated balloon (DCB) for a potential new indication in patients with end-stage renal disease. The randomized study will evaluate the IN.PACT Admiral DCB as a treatment for failing arteriovenous (AV) fistulas in these patients as compared to plain balloon angioplasty. The IDE approval enables Medtronic to initiate the study and gain safety and effectiveness data for the device in this investigational indication.
February 08, 2017
News | Atherectomy Devices
LIBERTY 360 Study Demonstrates Sustained Benefit of Endovascular Intervention in Lower Extremity PAD
February 8, 2017 — Cardiovascular Systems (CSI) presented six-month data from its LIBERTY 360° post-market study in a ...
February 08, 2017Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
News | Heart Failure
A new anticancer agent in development promotes regeneration of damaged heart muscle — an unexpected research finding that may help prevent congestive heart failure in the future.
February 07, 2017
News | Pharmaceuticals
GE Healthcare’s Life Sciences business announced in January that it acquired Rapidscan Pharma Solutions Inc., which has the exclusive rights to produce and sell the pharmacological stress agent Rapiscan (regadenoson) in territories outside the U.S., Canada and Mexico. GE Healthcare will help bring improved access to Rapiscan, offering an alternative screening method for patients who are unable to undergo traditional cardiac stress imaging procedures.
February 07, 2017
Technology | Cardiovascular Business
Healthcare analytics company Innovaccer Inc. announced the launch of its holistic MIPS Platform designed to enable providers to deliver better clinical outcomes. The platform does this by helping providers monitor performances, understand population, efficiently manage data and easily submit it to the Centers for Medicare and Medicaid Services (CMS).
February 07, 2017© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now